Top Markets
Coin of the day
Hyloris Pharmaceuticals S.A. Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A.

HYL
Clasificación en acciones #19935
Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and... Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.
Precio por acción
$5.22
Capitalización bursátil
$146.14M
Cambio (1 día)
-1.35%
Cambio (1 año)
-32.16%
País
BE
Comercio Hyloris Pharmaceuticals S.A. (HYL)

Categoría

Historial del precio de la acción de Hyloris Pharmaceuticals S.A. (HYL)
Precio más alto de cierre: $5.35 el 2026-08-01

Precio más bajo de cierre: $11.76 el 2020-06-01
Historial del precio de la acción de Hyloris Pharmaceuticals S.A. desde 2020 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -2.96%
2025 17.57%
2024 -54.17%
2023 -2.50%
2022 -29.03%
2021 58.84%
2020 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH